axsome therapeutics

  1. Axsome Therapeutics stock hits 34-month high

    After the slump on weak quarterly results, investors turned positive on Axsome Therapeutics (AXSM) stock, which climbed to the 34-month high of $11.33 on Monday. Traders were positive on the company’s patient enrollment in Migraine final trial as well as its commitment to developing therapies...
    • anonymous
    • Thread
    • axsome therapeutics
    • Replies: 0
    • Forum: Financial Forum

  2. Alzheimer’s disease trial - Axsome Therapeutics reports positive outcome

    Axsome Therapeutics stock skyrockets on positive outcome from Alzheimer's disease trial https://news.alphastreet.com/axsome-therapeutics-nasdaq-axsm-stock-almost-doubles-on-positive-outcome-from-alzheimers-disease-trial-in-premarket/
    • anonymous
    • Thread
    • alzhemier's disease axsome therapeutics biopharma clinical trial dementia drug eli lilly fda merck pfizer
    • Replies: 0
    • Forum: Pharma/Biotech Companies - In the News
Top Bottom
Back